• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

同一患者间歇性与持续性非卧床腹膜透析的纵向比较。

Longitudinal comparison of intermittent versus continuous ambulatory peritoneal dialysis, in the same patients.

作者信息

Madden M A, Zimmerman S W, Simpson D P

出版信息

Clin Nephrol. 1981 Dec;16(6):293-9.

PMID:6797767
Abstract

Twelve patients who had been on intermittent peritoneal dialysis (IPD) for an average of 18.3 months each, were switched to continuous ambulatory peritoneal dialysis (CAPD). CAPD experience is now 118 patient months (average 9.8 months per patient), and ten patients remain on CAPD. Serum chemistries reflected the change to continuous dialysis with a fall in serum creatinine, potassium, uric acid, phosphate, and BUN. The total CO2 rose markedly, indicating prevention of the recurrent metabolic acidosis experienced in IPD. Serum phosphate fell significantly into the normal range. Serum calcium rose slightly in six patients and significantly in three others. Serum alkaline phosphatase activity rose in seven patients, without development of clinical evidence of bone disease. Mean hematocrit values were higher in most patients of CAPD, but fell again after one year. The transient nature of the rise in hematocrit suggests that improved volume control, as reflected in blood pressure changes, may play a role in the frequently reported increase in hematocrit on CAPD. Despite an increase in peritonitis rate (one infection per 5.9 patient months on CAPD, versus one per 12.2 patient months on IPD), CAPD offers several distinct advantages over IPD, especially in control of uremic acidosis, phosphate retention, blood pressure and fluid management, as well as an overall improvement in physical and psychosocial well-being.

摘要

12名平均接受间歇性腹膜透析(IPD)18.3个月的患者转为持续性非卧床腹膜透析(CAPD)。目前CAPD的经验为118个患者月(平均每位患者9.8个月),10名患者仍在接受CAPD治疗。血清化学指标反映了向持续性透析的转变,血清肌酐、钾、尿酸、磷酸盐和尿素氮下降。总二氧化碳显著升高,表明预防了IPD中出现的反复代谢性酸中毒。血清磷酸盐显著下降至正常范围。6名患者的血清钙略有升高,另外3名患者的血清钙显著升高。7名患者的血清碱性磷酸酶活性升高,但未出现骨病的临床证据。大多数CAPD患者的平均血细胞比容值较高,但1年后再次下降。血细胞比容升高的短暂性表明,血压变化所反映的容量控制改善可能在CAPD中经常报道的血细胞比容升高中起作用。尽管腹膜炎发生率有所增加(CAPD为每5.9个患者月发生1次感染,IPD为每12.2个患者月发生1次感染),但与IPD相比,CAPD具有几个明显的优势,尤其是在控制尿毒症酸中毒、磷酸盐潴留、血压和液体管理方面,以及在整体身体和心理社会幸福感方面的改善。

相似文献

1
Longitudinal comparison of intermittent versus continuous ambulatory peritoneal dialysis, in the same patients.同一患者间歇性与持续性非卧床腹膜透析的纵向比较。
Clin Nephrol. 1981 Dec;16(6):293-9.
2
Twelve months' experience with continuous ambulatory and intermittent peritoneal dialysis.持续非卧床腹膜透析和间歇性腹膜透析的十二个月经验
Arch Intern Med. 1981 Feb;141(2):187-90.
3
Continuous ambulatory peritoneal dialysis (CAPD) in the treatment of end-stage renal failure.
Proc Eur Dial Transplant Assoc. 1979;16:171-7.
4
Continuous ambulatory peritoneal dialysis: three years' experience.持续性非卧床腹膜透析:三年经验
Q J Med. 1983 Spring;52(206):165-86.
5
[Continous ambulatory peritoneal dialysis (CAPD)].
Schweiz Med Wochenschr. 1979 Dec 29;109(50):1990-5.
6
[The effect of the number of peritonitis episodes on peritoneal membrane function].[腹膜炎发作次数对腹膜功能的影响]
Srp Arh Celok Lek. 1999 Jan-Feb;127(1-2):28-31.
7
Comparison of intermittent with continuous peritoneal dialysis.间歇性腹膜透析与持续性腹膜透析的比较。
Proc Eur Dial Transplant Assoc. 1978;15:197-204.
8
Comparison of continuous ambulatory peritoneal dialysis and hemodialysis in children.儿童持续性非卧床腹膜透析与血液透析的比较。
Kidney Int Suppl. 1986 Jul;19:S11-4.
9
Characteristics of the hematocrit response to continuous ambulatory peritoneal dialysis.
Arch Intern Med. 1984 Apr;144(4):728-32.
10
Continuous ambulatory peritoneal dialysis (CRPD)--an initial Indian experience.持续性非卧床腹膜透析(CRPD)——印度的初步经验。
J Indian Med Assoc. 2005 Jan;103(1):22, 24, 26 passim.

引用本文的文献

1
Combined peritoneal and haemodialysis therapy for chronic renal insufficiency.
Int Urol Nephrol. 1990;22(4):379-87. doi: 10.1007/BF02549800.